Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shu Gan Jian Pi Hua Tan Xing Qi decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by Guang'anmen Hospital of the Chinese Academy of Chinese Medical Sciences. It is specifically designed for the treatment of subclinical hypothyroidism, a condition characterized by elevated serum thyroid-stimulating hormone (TSH) levels despite normal free thyroxine (FT4) levels. The formula's name reflects its therapeutic principles in TCM: "Shu Gan" (soothing the liver), "Jian Pi" (strengthening the spleen), "Hua Tan" (transforming phlegm), and "Xing Qi" (promoting Qi circulation). It is currently being evaluated in multi-center, randomized controlled clinical trials to assess its efficacy in improving thyroid function and relieving clinical symptoms associated with the disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shu gan jian pi hua tan xing qi decoction.